<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>mobihealthnews&#187; CGM</title>
	<atom:link href="http://mobihealthnews.com/tag/cgm/feed/" rel="self" type="application/rss+xml" />
	<link>http://mobihealthnews.com</link>
	<description>mobihealthnews - the daily mHealth industry monitor.  Subscribe for our free weekly e-newsletter!</description>
	<lastBuildDate>Fri, 10 Feb 2012 19:24:35 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Shorts: CGM start-ups, studies; Intel&#8217;s reader</title>
		<link>http://mobihealthnews.com/5498/shorts-cgm-start-ups-studies-intels-reader/</link>
		<comments>http://mobihealthnews.com/5498/shorts-cgm-start-ups-studies-intels-reader/#comments</comments>
		<pubDate>Mon, 16 Nov 2009 14:35:54 +0000</pubDate>
		<dc:creator>Brian Dolan</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Aerotel]]></category>
		<category><![CDATA[CGM]]></category>
		<category><![CDATA[continuous blood glucose]]></category>
		<category><![CDATA[ECG]]></category>
		<category><![CDATA[Echo Therapeutics]]></category>
		<category><![CDATA[Intel]]></category>
		<category><![CDATA[Intel Digital Health Group]]></category>
		<category><![CDATA[Intel Reader]]></category>
		<category><![CDATA[Medtronic]]></category>
		<category><![CDATA[Tomorrow Options]]></category>
		<category><![CDATA[WalkinSense]]></category>
		<category><![CDATA[wireless implantable devices]]></category>

		<guid isPermaLink="false">http://mobihealthnews.com/?p=5498</guid>
		<description><![CDATA[CGM start-up raises $3M: Echo Therapeutics, which is developing a needle-free, non-invasive, wireless, transdermal continuous glucose monitoring system and and a system for transdermal drug delivery, raised $3 million in additional capital by selling common stock to accredited and institutional investors. More
Medtronic points to studies lauding CGM: “It’s very exciting to see the evidence unfold [...]]]></description>
		<wfw:commentRss>http://mobihealthnews.com/5498/shorts-cgm-start-ups-studies-intels-reader/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
	</channel>
</rss>

<!-- Dynamic Page Served (once) in 1.288 seconds -->

